J.R. Greene is chief executive officer of Psychiatric Medical Care, the nation’s largest behavioral healthcare management company with over 400 hospital and health system partners in more than 35 states.
Prior to his career in behavioral healthcare, Greene held leadership roles in marketing and sales at the Coca-Cola Company, Procter & Gamble, and Revlon. Greene is a fellow of the American College of Healthcare Executives, a board member of the Nashville Healthcare Council, and a member of the University of Tennessee Health Science Center College of Medicine Board of Visitors.
Greene drew national attention as the “Big Orange Tux Guy” when he led UT’s football team onto the field for the 1999 national championship game. Learn more about this funny story at volstux.com.
Nancy-Ann DeParle is a partner and co-founder of Consonance Capital Partners, a private equity firm focused on investing in innovative health care companies in the lower middle-market. She is also a director of CVS Caremark, HCA Health, and Enclara Healthcare and served on the board of KEPRO. From 2011-January 2013, she was Assistant to the President and Deputy Chief of Staff for Policy in the Obama White House. A health policy expert, DeParle previously served as Counselor to the President and Director of the White House Office of Health Reform. She spearheaded President Obama’s successful effort to enact the Affordable Care Act and managed the initial implementation of the law.
From 2006-2009, DeParle was a Managing Director of CCMP Capital Advisors, a private equity firm, and a senior advisor to its predecessor, JPMorgan Partners, LLC. She was also a Senior Fellow at the Wharton School of the University of Pennsylvania and a trustee or director of several corporate and non-profit boards. From 1997-2000, DeParle was Administrator of the agency now known as the Centers for Medicare and Medicaid Services (CMS). She directed Medicare, Medicaid, and State Children’s Health Insurance (SCHIP), which provide health insurance for more than 105 million Americans at an annual cost of $870 billion. Earlier in her career, she served as Associate Director for Health and Personnel at the White House Office of Management and Budget (OMB), and as Commissioner of the Tennessee Department of Human Services.
A native of Rockwood, Tennessee, DeParle received a B.A. with highest honors from the University of Tennessee, where she was Student Body President, and a J.D. from Harvard Law School. She also received a B.A. and M.A. in Politics and Economics from Balliol College of Oxford University, where she was a Rhodes Scholar.
Mitchell Blutt, MD is the CEO of Consonance Capital, a health care focused investment firm. He is the former Executive Partner of J.P. Morgan Partners (JPMP). He is also a Clinical Assistant Professor of Medicine, in the Department of Medicine at Weill Cornell Medicine.
Dr. Blutt completed his BA and MD degrees from the University of Pennsylvania. He received his MBA at the Wharton School of the University of Pennsylvania through the Clinical Scholars Fellowship sponsored by the Robert Wood Johnson Foundation. He completed his residency in Internal Medicine at New York-Presbyterian/Weill Cornell Medical Center.
Dr. Blutt has served on numerous boards of directors, including Cardinal Health, Cooper Holding, DJ Orthopedics, Fisher Scientific, General Medical, Hanger Orthopedic Group, Medical Arts Press, Tenax, Thermoscan and KEPRO. He also formerly served on the Board of the Michael J. Fox Foundation for Parkinson’s Research, the Board of Trustees of Penn Medicine (the Health System of the University of Pennsylvania), the Board of Trustees of the University of Pennsylvania, and the Board of The Brearley School. He currently serves on the Board of Overseers of the University of Pennsylvania School of Arts and Sciences and is the Chairman of the External Advisory Board of CHIBE (Center for Health Incentives and Behavioral Economics) at the University of Pennsylvania. Dr. Blutt is a recipient of the Alumni Award of Merit, the University of Pennsylvania’s highest honor. He serves on the Board of Overseers of Weill Cornell Medicine and is on the Executive Committee of the Dean’s Council, an advisory board to the Dean. Dr. Blutt is also a member of the New York Weill Cornell Council, an advisory board to the New York-Presbyterian/Weill Cornell Medical Center. He serves on the Board of Directors of The Commonwealth Fund, a private foundation that supports independent research on health and social issues and makes grants to improve health care practice and policy. Dr. Blutt also serves on the Board of Bako, a premier national provider of specialty laboratory testing and other high quality pathology services, and PMC (Psychiatric Medical Care), the leading operator of inpatient and outpatient behavioral health programs in rural communities.
Dr. Blutt founded Consonance Capital in 2005.
Stephen McKenna is a Managing Partner and Co-Founder of Consonance Capital Partners. Prior to founding CCP, he was a Managing Director at JPMP, where he focused on making growth equity and buyout investments. Stephen served on numerous boards, including KEPRO, Generac Power Systems, Jetro Holdings, National Waterworks, and PQ Corp. Prior to joining JPMP in early 2000, Stephen worked in the Investment Banking Group of Morgan Stanley and the Mergers & Acquisitions Group of JPMorgan. Stephen holds a BA from Dartmouth College and an MBA from the University of Chicago Booth School of Business.
Brent Turner is the Chief Executive Officer of Summit Behavioral Healthcare. Formerly, he was President of Acadia Healthcare Company Inc. (NASDAQ:ACHC), having served as President since joining Acadia in 2011. Prior to joining Acadia, he served as the Executive Vice President of Finance and Administration of Psychiatric Solutions, Inc.
Turner serves on the Board of Directors of LHC Group, Inc. (NASDAQ:LHCG) and Surgery Partners, Inc. (NASDAQ:SGRY) and previously served as Chairman of the National Association for Behavioral Healthcare (NABH). Turner graduated from Vanderbilt University in 1988 with a Bachelor of Arts degree in Economics. He received his MBA from the Vanderbilt Owen Graduate School of Management in Nashville, TN, in 1989.
